Grow Your Pharma Business Digitally
Virtual Booth
Contact Supplier
Product Reset all filters
01 1Bylvay
Odevixibat
Ipsen
Main Therapeutic Indication : Rare Diseases
Currency : USD
2023 Revenue in Millions : 80
2022 Revenue in Millions : 0
Growth (%) : Acquired from Albireo
Portfolio PDF
Product Web Link
Digital Content
Website
Corporate PDF